Tariq Musa has made recent disclosures regarding his stock transactions in an SEC filing, which could impact perceptions of his involvement with Guardant Health, Inc. The filing details transactions involving common stock and restricted stock units, indicating Musa's active role in the company.
Background
Tariq Musa is associated with Guardant Health, Inc., a company operating in the medical laboratories sector. The company is listed under the CIK number 0001576280. Recent filings include a Form 4 on October 19, 2026, which details Musa's stock transactions.
What the Filing Says
The filing indicates that on October 15, 2026, Musa acquired 250 shares of common stock and 250 restricted stock units, both marked with a transaction code of 'M' for acquisition. Additionally, on October 16, 2026, he disposed of 116 shares of common stock at a price of $165.88 per share. Following these transactions, Musa now owns 11,583 shares of common stock and 1,250 shares from restricted stock units.
Impact
This update may influence investor sentiment regarding Guardant Health, Inc., particularly as it reflects insider activity from a key individual within the company. Stakeholders and analysts may interpret these transactions as a sign of confidence or concern about future performance.
What's Next
The filing does not say what happens next.